Recombinant Anti-CD55 x Anti-HLA-A Bispecific Antibody (scFv-Fc) (BSCFV-124)

Recombinant Anti-CD55 x Anti-HLA-A Bispecific Antibody (scFv-Fc) is formed by fusing two different scFv fragments to the hinge and Fc regions, in which the Fc region are engineered by KIH. Two of scFv moiety has the antibody variable domain of either anti-CD55 specificity or anti-HLA-A specificity, which produces bivalent IgG-like molecules with desired characteristics of intact antibodies. This BsAb can recruit complements to tumor cells. It is designed for the research of Renal cell cancer (RCC); Solid tumors therapy.

Datasheet INQUIRY

Specifications

Targets

CD55 & HLA-A

Type

scFv-based Bispecific Fragments

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Renal cell cancer (RCC); Solid tumors

Targets

Target 1

CD55

Gene ID

1604

UniProt ID

P08174

Alternative Names

CD55; CD55 molecule, decay accelerating factor for complement (Cromer blood group); CR; TC; DAF; CROM; complement decay-accelerating factor; CD55 antigen

Target 2

HLA-A

Gene ID

3105

UniProt ID

P30443

Alternative Names

HLA-A; major histocompatibility complex, class I, A; HLAA; HLA class I histocompatibility antigen, A-1 alpha chain; antigen presenting molecule; leukocyte antigen class I-A; MHC class I antigen HLA-A heavy chain

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-CD55 x Anti-HLA-A Bispecific Antibody (scFv-Fc) (BSCFV-124). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-CD55 x Anti-HLA-A Bispecific Antibody (scFv-Fc) (CAT#: BSCFV-124)

Specifications

Targets

Customer Reviews and Q&As